CRISPR/Cas9 gene editing boosts effectiveness of ultrasound cancer therapy



CRISPR/Cas9 gene editing boosts effectiveness of ultrasound cancer therapy

Sonodynamic therapy uses ultrasound in combination with drugs to release harmful reactive oxygen species (ROS) at the site of a tumor. However, the treatment isn’t very effective because cancer cells can activate antioxidant defense systems to counteract it. Now, researchers have breached these defenses with CRISPR/Cas9 gene editing, allowing sonodynamic therapy to effectively shrink tumors in a mouse model of liver cancer.

Materials provided by American Chemical Society. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

9th December 2022

Clues found regarding tumor suppressor gene's breast cancer activity

Read more
9th December 2022

New findings on how to avert excessive weight loss from COVID-19

Read more
9th December 2022

P53 could be key to therapies for salivary gland cancer

Read more